SCHEDULE 13D

Company

SUPERNUS PHARMACEUTICALS, INC.

Filed

May 14, 2012

Accession Number

0000947871-12-000436

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →